Drug Profile
Research programme: Rac GTPase inhibitors - P2D Bioscience
Alternative Names: PD-3766Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cincinnati Childrens Hospital Medical Center; P2D Bioscience
- Class Small molecules
- Mechanism of Action Rac GTP-binding protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lung disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Lung-disorders in USA
- 19 Jul 2011 Preclinical trials in Lung disorders in USA (unspecified route)